From: Pilot study comparing the two hemostatic agents in patients undergoing partial nephrectomy
Variable | Total cohort (N = 23) | Floseal® cohort (N = 11) | Arista® cohort (N = 12) | p value |
---|---|---|---|---|
Mean age (±SD, years) | 57.9 ± 10.4 | 55.0 ± 9.6 | 60.5 ± 10.9 | 0.45 |
Male:female | 13:10 | 7:4 | 6:6 | .51 |
Race | 0.40 | |||
Caucasian | 12 (52%) | 5 (46%) | 7 (58%) | |
African American | 3 (13%) | 1 (8%) | 2 (17%) | |
Latinos | 7 (31%) | 5 (46%) | 2 (17%) | |
Others | 1 (4%) | 0 (0%) | 1 (8%) | |
Tobacco history | 12 (52%) | 6 (55%) | 6 (50%) | 0.82 |
Mean BMI (± SD, kg/m2) | 30.2 ± 4.5 | 29.6 ± 2.8 | 30.8 ± 5.7 | 0.56 |
Mean Preoperative GFR (±SD, mL/min/1.73 m2) | 82.0 ± 19.2 | 82.0 ± 25.3 | 82.0 ± 12.5 | 1.00 |
Side of renal mass (R/L) | 5/18 | 1/10 | 4/8 | 0.15 |
Median size of renal mass (cm) | 4.3 (range, 1.5-7 ) | 4.4 ± 1.8 | 4.2 ± 1.4 | 0.70 |